Author

Darren Hodgson

AstraZeneca (United Kingdom)ORCID 0000-0002-6631-9626Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Asbjørn KjæriD· 1 shared Christopher AbboshiD· 1 shared Deema Radif· 1 shared Hugo J.W.L. AertsiD· 1 shared Iver NordentoftiD· 1 shared Johanne AhrenfeldtiD· 1 shared Jørgen Bjerggaard JenseniD· 1 shared Karin Birkenkamp‐DemtröderiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Asbjørn KjærORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCell Reports MedicinePeer-reviewedMay 1, 2025

Low T cell diversity is associated with poor outcome in bladder cancer: a comprehensive longitudinal analysis of the T cell receptor repertoire

Asbjørn Kjær, Nanna Kristjánsdóttir, Randi Istrup Juul…·Lars Dyrskjøt

This study shows that low T cell receptor diversity in bladder cancer patients is linked to poor outcomes and identifies TCR diversity as a potential biomarker for treatment.

9 citations

humanbulk RNA-seq

𝕏 PostBluesky